Office Lease SHOREBREEZE SHOREBREEZE I REDWOOD CITY, CALIFORNIA Between CA- SHOREBREEZE LIMITED PARTNERSHIP, a Delaware limited partnership as Landlord, and VERSARTIS, Inc., a Delaware corporation as TenantOffice Lease • February 18th, 2014 • Versartis, Inc. • Pharmaceutical preparations • California
This Office Lease (this “Lease”), dated as of the date set forth in Section 1.1. is made by and between CA-SHOREBREEZE LIMITED PARTNERSHIP, a Delaware limited partnership (“Landlord”), and VERSARTIS, INC, a Delaware corporation (“Tenant”). The following exhibits are incorporated herein and made a part hereof Exhibit A (Outline of Premises); Exhibit B (Work Letter); Exhibit B-1 (Space Plan); Exhibit C (Form of Confirmation Letter); Exhibit D (Rules and Regulations); Exhibit E (Judicial Reference); and Exhibit F (Additional Provisions).
TECHNOLOGY TRANSFER AND CLINICAL SUPPLY AGREEMENTTechnology Transfer and Clinical Supply Agreement • February 18th, 2014 • Versartis, Inc. • Pharmaceutical preparations
[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
VERSARTIS, INC. FOURTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT February 14, 2014Investors Rights Agreement • February 18th, 2014 • Versartis, Inc. • Pharmaceutical preparations • Delaware
THIS FOURTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (the “Agreement”) is made as of the 14th day of February, 2014, by and among Versartis, Inc., a Delaware corporation (the “Company”), and the investors listed on Schedule A hereto, each of which is herein referred to as an “Investor.”
AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED LICENSING AGREEMENTLicensing Agreement • February 18th, 2014 • Versartis, Inc. • Pharmaceutical preparations • California
This Amendment No. 1 (“Amendment No. 1”) to the Second Amended and Restated Licensing Agreement dated December 30, 2010 (the “Agreement”) by and between Amunix Operating, Inc. (“Licensor”) and Versartis, Inc. (“Licensee”).
ContractAssignment of Agreement • February 18th, 2014 • Versartis, Inc. • Pharmaceutical preparations
[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
Amendment No. 1 (hereinafter the “Amendment No. 1”) to the Technology Transfer, Clinical Supply Agreement dated October 23, 2012, (hereinafter the “Agreement”)Technology Transfer, Clinical Supply Agreement • February 18th, 2014 • Versartis, Inc. • Pharmaceutical preparations
Whereas, the Parties intend on continuing their good relationship and are now desirous to perform additional cGMP fill and finish and drug substance services under the
SECOND AMENDED AND RESTATED LICENSING AGREEMENTLicensing Agreement • February 18th, 2014 • Versartis, Inc. • Pharmaceutical preparations • California
This Second Amended and Restated License Agreement (“Agreement”) is entered into effective December 30, 2010 (“Effective Date”) by and between Amunix Operating, Inc. (“Licensor”), a Delaware corporation, and Versartis, Inc. (“Licensee”), a Delaware corporation.
SERVICES AGREEMENTServices Agreement • February 18th, 2014 • Versartis, Inc. • Pharmaceutical preparations
This Services Agreement (“Agreement”) is entered into by and between Amunix Operating Inc. (“Amunix”), a Delaware corporation, having an office at 500 Ellis Street, Mountain View, CA 94043 and Versartis, Inc. (“Versartis”), a Delaware corporation, having an office at 275 Shoreline Drive, Suite 450, Redwood City, CA 94065, effective as of March 18, 2013 (the “Effective Date”). Any capitalized terms not defined herein shall be given the meaning set forth in that certain Second Amended and Restated Licensing Agreement of December 30, 2010 herewith between Versartis and Amunix Operating, Inc., as amended by a certain Amendment No. 1 to the Second Amended and Restated Licensing Agreement effective as of January 7, 2013 (together, the “Amended License Agreement”).
VERSARTIS, INC.Second Amended and Restated License Agreement • February 18th, 2014 • Versartis, Inc. • Pharmaceutical preparations • California
This Letter Agreement (this “Letter Agreement”) is made effective as of February 3, 2011 by and between Versartis, Inc., a Delaware corporation (the “Licensee”) and Amunix Operating, Inc., a Delaware corporation (the “Licensor”). This Letter Agreement makes reference to that certain Second Amended and Restated Licensing Agreement between Licensor and Licensee, dated December 30, 2010 (the “Licensing Agreement”).
